Roflumilast: Review of Phosphodiesterase-4 Inhibitor as Asthma Therapy
Asthma is a heterogeneous disease characterized by chronic inflammation of the airways induced reversible obstruction resulting in mortality and morbidity. Roflumilast is a second-generation selective inhibitor of phosphodiesterase-4 targeting PDE type 4 isoenzymes, disturbing the breakdown of cycl...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Книга |
| Опубліковано: |
Universitas Nahdlatul Ulama Surabaya,
2021-08-01T00:00:00Z.
|
| Предмети: | |
| Онлайн доступ: | Connect to this object online. |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Інтернет
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Примірник 1 | Доступно |